Dear all, After a successful Batch 2 of Healthcare Xplorers, we are back at it again with 3 exciting new data challenges <https://healthcare-xplorers.com/challenges/>. Check it out! _______ Are you a student or PhD and want to boost your career? Do you love data and to think out-of-the-box? Then take your chance and bring your idea to life with Roche. Participating is really easy: have a look at our challenges, select the one you want to tackle and submit your idea (3 to 5 PPT slides). Read more on how it works <https://healthcare-xplorers.com/how-it-works/>. Please note: You will have time to submit your idea until mid July 2021. Challenge 1: Augmented patient pathways in oncology <https://healthcare-xplorers.com/challenges/augmented-patient-pathways-in-oncology/> Challenge 2: Develop machine learning-based methods for early anomaly detection in diagnostics instrument and assay data <https://healthcare-xplorers.com/challenges/develop-machine-learning-based-methods-for-early-anomaly-detection-in-diagnostics-instrument-and-assay-data/> Challenge 3: Generating synthetic patient-reported outcomes to foster collaboration in clinical settings <https://healthcare-xplorers.com/challenges/generating-synthetic-patient-reported-outcomes-to-foster-collaboration-in-clinical-settings/> Greenfield Challenge: Do you have another great idea which you would like to put into practice with Roche as a partner? Propose a data-driven healthcare project to us here <https://healthcare-xplorers.com/challenges/greenfield-challenge/> Any questions? Please feel free to contact us: healthcare.xplorers(a)roche.com Your Healthcare Xplorers team -- *HealthcareXplorers-Team* *Academic Minds for Innovation* Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / Germany mailto:healthcarexplorers@roche.com &lt;healthcarexplorers(a)roche.com&gt; Roche Diagnostics GmbH Sandhofer Straße 116; D‑68305 Mannheim; Telefon +49‑621‑759‑0; Telefax +49‑621‑759‑2890 Sitz der Gesellschaft: Mannheim - Registergericht: AG Mannheim HRB 3962 - Geschäftsführung: Claus Haberda; Andreas Schmitz - Aufsichtsratsvorsitzender: Dr. Thomas Schinecker Confidentiality Note This message is intended only for the use of the named recipient(s) and may contain confidential and/or privileged information. If you are not the intended recipient, please contact the sender and delete the message. Any unauthorized use of the information contained in this message is prohibited.